These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 14524580)

  • 1. Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure.
    Frank H; Werner D; Lorusso V; Klinghammer L; Daniel WG; Kunzendorf U; Ludwig J
    Clin Nephrol; 2003 Sep; 60(3):176-82. PubMed ID: 14524580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial.
    Lee PT; Chou KJ; Liu CP; Mar GY; Chen CL; Hsu CY; Fang HC; Chung HM
    J Am Coll Cardiol; 2007 Sep; 50(11):1015-20. PubMed ID: 17825709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
    Thomsen HS; Morcos SK; Erley CM; Grazioli L; Bonomo L; Ni Z; Romano L;
    Invest Radiol; 2008 Mar; 43(3):170-8. PubMed ID: 18301313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysis.
    Lorusso V; Taroni P; Alvino S; Spinazzi A
    Invest Radiol; 2001 Jun; 36(6):309-16. PubMed ID: 11410750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency.
    Huber W; Schipek C; Ilgmann K; Page M; Hennig M; Wacker A; Schweigart U; Lutilsky L; Valina C; Seyfarth M; Schömig A; Classen M
    Am J Cardiol; 2003 May; 91(10):1157-62. PubMed ID: 12745095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term renal outcomes of immediate prophylactic hemodialysis after cardiovascular catheterizations in patients with severe renal insufficiency.
    Hsieh YC; Ting CT; Liu TJ; Wang CL; Chen YT; Lee WL
    Int J Cardiol; 2005 Jun; 101(3):407-13. PubMed ID: 15907408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.
    Kay J; Chow WH; Chan TM; Lo SK; Kwok OH; Yip A; Fan K; Lee CH; Lam WF
    JAMA; 2003 Feb; 289(5):553-8. PubMed ID: 12578487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography.
    Manske CL; Sprafka JM; Strony JT; Wang Y
    Am J Med; 1990 Nov; 89(5):615-20. PubMed ID: 2239981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of contrast-induced nephropathy with ascorbic acid.
    Zhou L; Chen H
    Intern Med; 2012; 51(6):531-5. PubMed ID: 22449658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study.
    Jo SH; Koo BK; Park JS; Kang HJ; Cho YS; Kim YJ; Youn TJ; Chung WY; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
    Am Heart J; 2008 Mar; 155(3):499.e1-8. PubMed ID: 18294484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful.
    Vogt B; Ferrari P; Schönholzer C; Marti HP; Mohaupt M; Wiederkehr M; Cereghetti C; Serra A; Huynh-Do U; Uehlinger D; Frey FJ
    Am J Med; 2001 Dec; 111(9):692-8. PubMed ID: 11747848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy.
    Kurnik BR; Allgren RL; Genter FC; Solomon RJ; Bates ER; Weisberg LS
    Am J Kidney Dis; 1998 Apr; 31(4):674-80. PubMed ID: 9531185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy.
    Tumlin JA; Wang A; Murray PT; Mathur VS
    Am Heart J; 2002 May; 143(5):894-903. PubMed ID: 12040355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
    Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
    G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine.
    Rashid ST; Salman M; Myint F; Baker DM; Agarwal S; Sweny P; Hamilton G
    J Vasc Surg; 2004 Dec; 40(6):1136-41. PubMed ID: 15622367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous venovenous hemofiltration after coronary procedures for the prevention of contrast-induced acute kidney injury in patients with severe chronic renal failure.
    Guastoni C; Bellotti N; Poletti F; Covella P; Gidaro B; Stasi A; Seveso G; D'Urbano M; Mariani M; De Servi S
    Am J Cardiol; 2014 Feb; 113(4):588-92. PubMed ID: 24321895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of iomeprol by hemodialysis.
    Ueda J; Furukawa T; Higashino K; Takahashi S; Araki Y; Sakaguchi K
    Eur J Radiol; 1996 Nov; 23(3):197-200. PubMed ID: 9003924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast induced nephropathy in patients with pre-existing renal impairment undergoing coronary angiogram and percutaneous transluminal coronary angioplasty.
    Subedi B; Siddique MA; Zaman SM; Hasan MI; Arzu J; Awal A; Fatema K
    Mymensingh Med J; 2011 Apr; 20(2):270-4. PubMed ID: 21522099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
    Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
    Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.